Flexible micro spring array device for high-throughput enrichment of viable circulating tumor cells

Clinical Chemistry

Volumn 60, Issue 2, 2014, Pages 323-333

  Harouaka, Ramdane A ^a,b   Zhou, Ming Da ^a,b   Yeh, Yin Ting ^a,b   Khan, Waleed J ^a,b   Das, Avisnata ^b   Liu, Xin ^b   Christ, Christine C ^b   Dicker, David T ^b   Baney, Tara S ^b   Kaifi, Jussuf T ^c   Belani, Chandra P ^b   Truica, Cristina I ^b   El Deiry, Wafik S ^b   Allerton, Jeffrey P ^b   Zheng, Si Yang ^a,b  

^a The Pennsylvania State University   (United States)

^b PENN STATE CANCER INSTITUTE   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; BLOOD VOLUME; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL DAMAGE; CELL FREE SYSTEM; CELL PROLIFERATION; CELL VIABILITY; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLEXIBLE MICRO SPRING ASSAY DEVICE; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CANCER; MALE; MICROARRAY ANALYSIS; MICROARRAY KIT; MICROFILTRATION; MIDDLE AGED; TUMOR CELL; BIOLOGICAL MODEL; CELL COUNT; CELL SEPARATION; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; DEVICES; EQUIPMENT DESIGN; HIGH THROUGHPUT SCREENING; LEUKOCYTE; PATHOLOGY; PROCEDURES; TISSUE MICROARRAY; TUMOR CELL LINE; TUMOR EMBOLISM;

CELL COUNT; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; EQUIPMENT DESIGN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LEUKOCYTES; MODELS, BIOLOGICAL; NEOPLASTIC CELLS, CIRCULATING; TISSUE ARRAY ANALYSIS;

EID: 84893463269     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.206805     Document Type: Article

References (40)

1. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006;6:449-58.
2. Alix-Panabières C, Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013;59:110-8.
3. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91.
4. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007;450:1235-U10.
5. Talasaz AH, Powell AA, Huber DE, Berbee JG, Roh K-H, Yu W, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc Natl Acad Sci U S A 2009;106:3970-5.
6. Wang S, Liu K, Liu J, Yu Z T F, Xu X, Zhao L, et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew Cem Int Ed Engl 2011;50:3084-8.
7. Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res 2008;10:R69.
8. Kirby BJ, Jodari M, Loftus MS, Gakhar G, Pratt ED, Chanel-Vos C, et al. Functional characterization of circulating tumor cells with a prostate-cancerspecific microfluidic device. Plos One 2012;7:e35976.
9. Hughes AD, Mattison J, Western LT, Powderly JD, Greene BT, King MR. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood. Clin Chem 2012;58:846-53.
10. Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007;13:7053-8.
11. Cohen SJ, Punt C J A, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008;26:3213-21.
12. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, et al. Circulating tumor cells versus imaging-predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006;12:6403-9.
13. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006;12:4218-24.
14. Went PT, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S. Frequent EpCAM protein expression in human carcinomas. Hum Pathol 2004;35:122-8.
15. Christofori G. New signals from the invasive front. Nature 2006;441:444-50.
16. Klonisch T, Wiechec E, Hombach-Kionisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M. Cancer stem cell markers in common cancers-therapeutic implications. Trends Mol Med 2008;14:450-60.
17. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008;133:704-15.
18. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps R, et al. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002;49:150-8.
19. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000;156:57-63.
20. Marrinucci D, Bethel K, Kolatkar A, Luttgen MS, Malchiodi M, Baehring F, et al. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers. Phys Biol 2012;9:016003.
21. Wendel M, Bazhenova L, Boshuizen R, Kolatkar A, Honnatti M, Cho EH, et al. Fluid biopsy for circulating tumor cell identification in patients with early- and late-stage non-small cell lung cancer: a glimpse into lung cancer biology. Phys Biol 2012;9:016005.
22. Cho EH, Wendel M, Luttgen M, Yoshioka C, Marrinucci D, Lazar D, et al. Characterization of circulating tumor cell aggregates identified in patients with epithelial tumors. Phys Biol 2012;9:016001.
23. Tan SJ, Lakshmi RL, Chen PF, Lim WT, Yobas L, Lim CT. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron 2010;26:1701-5.
24. Hou HW, Warkiani ME, Khoo BL, Li ZR, Soo RA, Tan DS, et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci Rep 2013;3:1259.
25. Fleischer RL, Price PB, Symes EM. Novel filter for biological materials. Science 1964;143:249-50.
26. Seal SH. A sieve for the isolation of cancer cells and other large cells from the blood. Cancer 1964;17:637-42.
27. Fleischer R, Alter H, Furman S, Price P, Walker R. Particle track etching. Science 1972;178:255-63.
28. Vona G, Estepa L, Beroud C, Damotte D, Capron F, Nalpas B, et al. Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 2004;39:792-7.
29. Zheng S, Lin HK, Liu JQ, Balic M, Datar R, Cote RJ, Tai YC. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 2007;1162:154-61.
30. Lin HK, Zheng S, Williams AJ, Balic M, Groshen S, Scher HI, et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin Cancer Res 2010;16:5011-8.
31. Kuo JS, Zhao YX, Schiro PG, Ng LY, Lim D S W, Shelby JP, Chiu DT. Deformability considerations in filtration of biological cells. Lab Chip 2010;10:837-42.
32. Zheng S, Lin HK, Lu B, Williams A, Datar RH, Cote RJ, Tai YC. 3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood. Biomed Microdevices 2011;13:203-13.
33. Xu T, Lu B, Tai YC, Goldkorn A. A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter. Cancer Res 2010;70:6420-6.
34. Stott SL, Hsu C-H, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci U S A 2010;107:18392-7.
35. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580-4.
36. Fidler IJ. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 1973;9:223-7.
37. Liotta LA, Saldel GM, Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976;36:889-94.
38. Kalluri R, Weinberg RA. The basics of epithelialmesenchymal transition. J Clin Invest 2009;119:1420-8.
39. Armstrong AJ, Marengo MS, Oltean S, Kemeny G, Bitting RL, Turnbull JD, et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res 2011;9:997-1007.
40. Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria J, Farace F. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 2011;105:1338-41.